fingolimod hydrochloride has been researched along with acid phosphatase in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (acid phosphatase) | Trials (acid phosphatase) | Recent Studies (post-2010) (acid phosphatase) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 24,029 | 223 | 1,701 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amling, M; Bindl, R; Haffner-Luntzer, M; Heilmann, A; Ignatius, A; Liedert, A; Rapp, A; Schinke, T; Wehner, T | 1 |
1 other study(ies) available for fingolimod hydrochloride and acid phosphatase
| Article | Year |
|---|---|
Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice.
Topics: Acid Phosphatase; Animals; Biomechanical Phenomena; Bone Regeneration; Female; Fingolimod Hydrochloride; Fracture Healing; Mice; Mice, Inbred C57BL; Osteoclasts; Propylene Glycols; Sphingosine | 2013 |